DSM expands its innovative biomanufacturing technology portfolio with the introduction of the new Kremer Method™
View press release

PharmaTelevision Special Report on DSM Pharmaceutical Products
View now

Reducing Downstream Harvest Steps for Improved Bioprocess Economics
Genetic Engineering & Biotechnology News Webinar, June 2011

Queensland Premier, Hon. Anna Bligh, and Karen King, President DSM Biologics, discuss partnership for new drug manufacturing facility in Brisbane. View Interview

“Royal DSM is the ideal partner for this important initiative. We were impressed with the experience, expertise and technologies of DSM Biologics.” David Hughes, CEO of BioPharmaceuticals Australia. View video
Dr. Anna Lavelle, CEO of AusBiotech Ltd, Australia's Biotechnology Industry Organisation, talks about working with DSM. View video

Karen King
President and Business Unit Director, DSM Biologics
View video ''Optimized Technologies''